Reproducibility

CN Bio Wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for Ongoing Research With the FDA

Retrieved on: 
Thursday, November 23, 2023
Research, FDA, Clinical Trials, Professional Services, Biotechnology, Health, Data Analytics, Pharmaceutical, Science, OOC, Reproducibility, Food, MPS, Government, Clinical and Translational Science, Patient, North American Menopause Society, Research fellow, Mills & Reeve, Drug discovery, Partnership, Human, NAM, Metabolism, Publication, Pharmaceutical industry

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has received the ‘Most Impactful Industry Collaboration of the Year’ at the 2023 OBN Awards.

Key Points: 
  • CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has received the ‘Most Impactful Industry Collaboration of the Year’ at the 2023 OBN Awards.
  • Around 90% of drug candidates reaching clinical trials fail, often due to poor clinical translatability between conventional animal models and humans.
  • Recent ground-breaking legislature, including the US Government’s FDA Modernization Act and similar acts from the Canadian Government have supported this.
  • Dr. Tomasz Kostrzewski, Chief Scientific Officer, commented: “It is a huge honour to have received Most Impactful Industry Collaboration of the Year at this year’s OBN Awards.

Willow Names Bob Gold & Associates Its Public Relations Agency of Record

Retrieved on: 
Tuesday, October 24, 2023
Online, Sports, Entertainment, Mobile Entertainment, Professional Services, Internet, Apps, Applications, Technology, Data Analytics, TV and Radio, Public Relations, Investor Relations, Communications, Cricket, Human, BG, Partnership, Reproducibility, Communication, Olympic Games, Bob Gold & Associates, Associate, Willow

Willow ( www.willow.tv ), offering more live, streaming and on-demand cricket than any other sports service, has selected Bob Gold & Associates (BG&A), a nationally recognized data-driven public relations and brand management firm, as its PR agency of record.

Key Points: 
  • Willow ( www.willow.tv ), offering more live, streaming and on-demand cricket than any other sports service, has selected Bob Gold & Associates (BG&A), a nationally recognized data-driven public relations and brand management firm, as its PR agency of record.
  • “We sought an agency capable of articulating the profound connection between Willow and the cricket-loving community.
  • Bob Gold & Associates, with its proven award-winning track record in effective storytelling and strategic marketing, stood out as an exemplary choice,” remarked Todd Myers, Chief Operating Officer at Willow.
  • I guess you can tell how excited we are to embrace this new – yet at the same time, historic sport,” said Bob Gold, President of Bob Gold & Associates.

Ibex Launches Galen™ Breast HER2, Supporting Improved Biomarker Scoring in Breast Cancer Patients

Retrieved on: 
Thursday, September 7, 2023
ER, PR, Ibex, HER2, Marie Cassidy, Cell, H&E, Biomarker, AstraZeneca, Reproducibility, IHC, Breast, TEL, Congress, TILS, Protein, Hospital, MD, Breast cancer, Patient, Laboratory, Daiichi Sankyo, European, Immunohistochemistry, AI3, AI, Oncology, Malignancy, MD Anderson Cancer Center, LVI, 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, Medical device, Medical imaging, Birth control, Nature, Pathology

TEL AVIV, Israel, Sept. 7, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced the launch of Galen™ Breast HER2, an AI-powered solution that aids pathologists in setting a higher standard for accurate and reproducible HER2 (human epidermal growth factor receptor 2) scoring in breast cancer patients.

Key Points: 
  • HER2, one of the proteins responsible for division and proliferation of breast cancer cells, is expressed in many breast tumors and its accurate assessment is critical for identifying patients who are likely to benefit from HER2-directed therapies.
  • Traditionally, pathologists evaluate HER2 in tumor samples visually, which may result in varied interpretations as scoring is semi-quantitative and thus somewhat subjective1.
  • Galen Breast HER2 was developed and validated by Ibex in collaboration with AstraZeneca and Daiichi Sankyo .
  • Information about Galen Breast HER2 and Galen Breast will be available at the 35th European Congress of Pathology in Dublin, Ireland, between September 9-13 (Ibex Medical Analytics - booth number 23).

Harbinger Health Announces Data Demonstrating Its Ability to Detect Early-Stage Multi-Cancer at the AACC Annual Scientific Meeting 2023

Retrieved on: 
Wednesday, July 26, 2023
Abstract, DNA, Methylation, AACC, Cancer, Prognosis, Biomarker, Cancer biomarker, ASCO, American Society of Clinical Oncology, HIV disease progression rates, Reproducibility, Patient, Sequence, Annual general meeting, Biology, Neoplasm, American Association for Clinical Chemistry, Society, PCR, Harbinger, Disease, Pharmaceutical industry, Medical imaging, Nucleic acid thermodynamics

CAMBRIDGE, Mass., July 26, 2023 /PRNewswire/ -- Harbinger Health ("Harbinger," "the Company"), a biotechnology company pioneering the detection of early cancer, today announced data demonstrating the development and advancement of its biology and machine-learning-driven platform, HarbingerHx. The data were presented via three poster abstracts accepted at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo being held in Anaheim, Calif. on July 23-27, 2023.

Key Points: 
  • The data were presented via three poster abstracts accepted at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo being held in Anaheim, Calif. on July 23-27, 2023.
  • "Harbinger is pushing into new frontiers of cancer screening by pairing our proprietary insight into the biology of cancer's origins with our powerful technology platform," said Stephen M. Hahn, M.D., CEO of Harbinger Health.
  • "We aim to turn cancer into a disease that can be managed rather than feared.
  • The abstracts, which are now publicly available, follow Harbinger's recently announced results demonstrating high sensitivity for early-stage multi-cancer detection at the 2023 American Society of Clinical Oncology (ASCO)'s 2023 Annual Meeting.

ShowSeeker Fills PR Spot With Bob Gold & Associates as Public Relations Agency of Record

Retrieved on: 
Thursday, June 1, 2023
Marketing, Data Management, Advertising, Communications, Technology, Software, Public Relations, Investor Relations, Communication, Comcast, Human, Adtech (company), Bob Gold & Associates, Gold, Ecosystem, ROI, Xfinity, BG, Reproducibility, Automation, Sales, Television, Associate

ShowSeeker , America’s fastest-growing cloud-based ad management platform, has selected the award-winning, data-driven public relations and marketing firm, Bob Gold & Associates (BG&A) , as its PR agency of record.

Key Points: 
  • ShowSeeker , America’s fastest-growing cloud-based ad management platform, has selected the award-winning, data-driven public relations and marketing firm, Bob Gold & Associates (BG&A) , as its PR agency of record.
  • The agency will help drive awareness and adoption of ShowSeeker while bolstering the company’s industry-leading advertising sales, planning and workflow management solutions.
  • Bob Gold & Associates has served numerous industry ad companies, from Comcast Spotlight to Viamedia, Canoe Ventures and many, many others.
  • The company has created an indispensable new ecosystem," said Bob Gold, President of Bob Gold & Associates.

Curacao Retailer Names Bob Gold & Associates Its Public Relations Agency of Record

Retrieved on: 
Monday, March 20, 2023
Fashion, Home Goods, Retail, Thought Leadership, Finance, Online Retail, Electronic Commerce, Discount, Variety, Foundation, Professional Services, Consumer Electronics, Digital Cash Management, Digital Assets, Philanthropy, Technology, Digital Marketing, Public Relations, Investor Relations, Marketing, Communications, Communication, Electronics, Hope, Human, Bob Gold & Associates, Associate, Reproducibility

Curacao , the largest Hispanic-serving retailer in the West Coast, announced today that it has selected Bob Gold & Associates , a nationally recognized data-driven public relations and brand management firm, as its PR agency of record.

Key Points: 
  • Curacao , the largest Hispanic-serving retailer in the West Coast, announced today that it has selected Bob Gold & Associates , a nationally recognized data-driven public relations and brand management firm, as its PR agency of record.
  • The agency will help build awareness for Curacao, and its Curacao Foundation, promoting the company’s customer-first approach as the retailer expands its footprint with new store locations.
  • “We needed an agency that could deliver high-impact storytelling about the value, quality, and price that Curacao offers its shoppers.
  • Bob Gold and his award-winning team have proven themselves to be effective communicators with relevant marketing strategies,” said Ariela Nerubay, Chief Marketing Officer at Curacao.

Web3 Innovator, Impossible Cloud, Selects Bob Gold & Associates as Its PR Agency of Record

Retrieved on: 
Tuesday, March 7, 2023
Software, Internet, Public Relations, Investor Relations, Data Management, Communications, Web3, Technology, Security, Cloud, Venture, SOC, Communication, InterPlanetary File System, Bob Gold & Associates, Failure, Associate, Reproducibility, Internet of things, Blockchain, Goodgame Studios, Human, Adtech (company), Impossible, IA Financial Group, Marketing, Video game, Cryptocurrency, Groupon

Impossible Cloud , the revolutionary cloud platform that offers decentralized, multi-service cloud solutions, has selected Bob Gold & Associates , a nationally recognized boutique public relations and marketing agency, as its public relations agency of record.

Key Points: 
  • Impossible Cloud , the revolutionary cloud platform that offers decentralized, multi-service cloud solutions, has selected Bob Gold & Associates , a nationally recognized boutique public relations and marketing agency, as its public relations agency of record.
  • Impossible Cloud has entirely flipped this dynamic and is bringing much needed change by utilizing web3 technology,” said Bob Gold, President & CEO, Bob Gold & Associates.
  • There’s no better choice than Bob Gold & Associates to communicate our message and share our story,” said Christian Kaul, Co-Founder of Impossible Cloud.
  • Bob Gold & Associates provides uniquely tailored strategies for a full spectrum of communication needs in today’s digital-first world.

Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema

Retrieved on: 
Wednesday, October 26, 2022
Method, Time, Risk, ASX, Paper, Analysis, Patient, Reproducibility, Research, BIS, IPD, Multimedia, Cancer, Lymphedema, Lymphatic system, Swelling, Breast cancer, Heart failure, Skin, Radiation, Level 1, Literature, Journal of Cancer Survivorship, Manuscript, FDA, Conditional sentence, Cohort study, Medical imaging

CARLSBAD, Calif., Oct. 26, 2022 /PRNewswire/ -- ImpediMed Limited (ASX: IPD) is pleased to announce publication of a systematic literature review showing that early detection and intervention of breast cancer-related lymphedema (BCRL) reduces rates of chronic lymphedema in breast cancer patients. The analysis also shows that L-Dex® testing is the detection method with the most extensive evidence of efficacy. L-Dex testing was also found to be cost effective, reproducible, and practical to implement for patient monitoring.

Key Points: 
  • Data consistently show reduced rates of chronic breast cancer-related lymphedema with early detection and intervention.
  • The manuscript, published in Journal of Cancer Survivorship, titled "Reducing rates of chronic breast cancerrelated lymphedema with screening and early intervention: an update of recent data" details an analysis of 12 studies including 2,907 breast cancer patients and is available online here: https://link.springer.com/article/10.1007/s11764-022-01242-8 .
  • "The results of this literature review provide further confidence to patients and clinicians that early detection and intervention reduces rates of chronic breast cancer-related lymphedema," commented Dr. Pat Whitworth, breast surgeon, Director of the Nashville Breast Center, and lead author on the paper.
  • These trials consistently show that, regardless of detection method, patients benefit from reduced rates of chronic lymphedema with early detection and intervention.

Global Monolithic Microwave IC Market Report (2022 to 2027) - Increasing Number of Space Programs Worldwide Presents Opportunities

Retrieved on: 
Tuesday, October 25, 2022
Meteorologist, Reproducibility, Law enforcement agency, Frequency band, Technology, Application, Law enforcement, Police, Communication, Component, Wood-plastic composite

6 Monolithic Microwave IC Market, by Component

Key Points: 
  • 6 Monolithic Microwave IC Market, by Component
    7 Monolithic Microwave IC Market, by Material Type
    7.6.1 Offers High Input Power Survivability of 40 Dbm, Eliminating Requirement for Power Limiter in Broadband Communication
    8 Monolithic Microwave IC Market, by Technology
    8.5.1 E-Phemts Provide Combination of High Gain, Low Noise, and Wide Dynamic Range in High-Linearity Mmic Applications
    8.6.1 Mhemt Offers Large Wafer Size, Increased Reproducibility, and Improved Established Packaging
    8.8.1 Mos Offers Highly Efficient Transmission and Reception of Signals, Low Power Dissipation, and High Noise Margins
    9 Monolithic Microwave Ic Market, by Frequency Band
    9.7.1 K Band is Mainly Used by Meteorologists, Police, and Law Enforcement Agencies
    10 Monolithic Microwave Ic Market, by Application

Kids Read Now Selected as Library of Congress 2022 Literacy Award Winner

Retrieved on: 
Thursday, September 22, 2022
Child, Student, Center, Innovation, Secondary research, Review, Learning, The, Book, Program, University of Wisconsin Experimental College, Reading, Reward, Wisconsin Center for Education Research, School, Parent, K-5, Congress, ESSA, University, KRN, Literacy, Humble High School, Tutoring, Toy, Reproducibility

DAYTON, Ohio, Sept. 22, 2022 /PRNewswire-PRWeb/ -- A literal badge of honor. We are humbled and thankful to be selected by The Library of Congress as one of just a few 2022 Successful Practice Honorees for our "implementation of highly successful practices in literacy promotion."

Key Points: 
  • K-5 in-home reading program, Kids Read Now, selected as one of twelve 2022 Library of Congress Successful Practice Honorees for their implementation of highly successful practices in literacy promotion.
  • Each year the Library of Congress reviews hundreds of nominated nonprofit organizations working to improve literacy outcomes around the world.
  • Kids Read Now (KRN) exhibited these traits over each of its ten years in operation, leading to this prestigious win.
  • Kids Read Now builds students' literacy skills while building family literacy and a lifelong love of reading.